Biologics Outsourcing Market - 2025-2033

September 2025 | 47 pages | ID: B63B70CA7B11EN
DataM Intelligence

Abstracts

Biologics Outsourcing Market reached US$ 20.10 billion in 2023 and is expected to reach US$ 64.57 billion by 2033, growing with a CAGR of 12.10% during the forecast period 2026-2033.

The Biologics Outsourcing Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Biologics Outsourcing Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Service Type

• Process Development*
• Cell Development
• Analytical Services
• Others

By Product

• Antibodies*
• Vaccines
• Cell and Gene Therapies
• Recombinant Proteins
• Others

By Process Stage

• Clinical*
• Phase I
• Phase II
• Phase III
• Commercial
• Research

By Source

• Mammalian*
• Microorganisms

By Outsourcing Model

• CDMO*
• CMO
• CRO

By End-User

• Biotech Companies*
• Pharmaceutical Companies
• Research Organizations
• Others

Regional Analysis for Biologics Outsourcing Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Biologics Outsourcing Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Service Type
2.4. Snippet by Product
2.5. Snippet by Process Stage
2.6. Snippet by Source
2.7. Snippet by Outsourcing Model
2.8. Snippet by End-User
2.9. Snippet by Region

3. DYNAMICS

3.1. Impacting Factors
  3.1.1. Drivers
    3.1.1.1. Expanding Biologics Pipeline
    3.1.1.2. CDMO Strategy & Expansion
  3.1.2. Restraints
    3.1.2.1. Supply-chain/Geopolitical Risks
    3.1.2.2. Regulatory & Compliance Complexity
  3.1.3. Opportunity
    3.1.3.1. Biosimilars Manufacturing Services
    3.1.3.2. Regional Expansion
  3.1.4. Impact Analysis

4. GLOBAL BIOLOGICS OUTSOURCING MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

4.1. Market Leaders and Pioneers
  4.1.1. Emerging Pioneers and Prominent Players
  4.1.2. Established leaders with largest largest-selling Brand
  4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
  4.3.1. North America
  4.3.2. Europe
  4.3.3. Asia Pacific
  4.3.4. South America
  4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics

5. GLOBAL BIOLOGICS OUTSOURCING MARKET: BY SERVICE TYPE

5.1. Introduction
  5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  5.1.2. Market Attractiveness Index, By Service Type
5.2. Process Development*
  5.2.1. Introduction
  5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Cell Development
5.4. Analytical Services
5.5. Others

6. GLOBAL BIOLOGICS OUTSOURCING MARKET: BY PRODUCT

6.1. Introduction
  6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  6.1.2. Market Attractiveness Index, By Product
6.2. Antibodies*
  6.2.1. Introduction
  6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Vaccines
6.4. Cell and Gene Therapies
6.5. Recombinant Proteins
6.6. Others

7. GLOBAL BIOLOGICS OUTSOURCING MARKET: BY PROCESS STAGE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Stage
  7.1.2. Market Attractiveness Index, By Process Stage
7.2. Clinical*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  7.2.3. Phase I
  7.2.4. Phase II
  7.2.5. Phase III
7.3. Commercial
7.4. Research

8. GLOBAL BIOLOGICS OUTSOURCING MARKET: BY SOURCE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  8.1.2. Market Attractiveness Index, By Source
8.2. Mammalian*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Microorganisms

9. GLOBAL BIOLOGICS OUTSOURCING MARKET: BY OUTSOURCING MODEL

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Outsourcing Model
  9.1.2. Market Attractiveness Index, By Outsourcing Model
9.2. CDMO*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. CMO
9.4. CRO

10. GLOBAL BIOLOGICS OUTSOURCING MARKET: BY END-USER

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  10.1.2. Market Attractiveness Index, By End-User
10.2. Biotech Companies*
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Pharmaceutical Companies
10.4. Research Organizations
10.5. Others

11. GLOBAL BIOLOGICS OUTSOURCING MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Stage
  11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Outsourcing Model
  11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.2.9.1. U.S.
    11.2.9.2. Canada
    11.2.9.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Stage
  11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Outsourcing Model
  11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.3.9.1. Germany
    11.3.9.2. U.K.
    11.3.9.3. France
    11.3.9.4. Spain
    11.3.9.5. Italy
    11.3.9.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Stage
  11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Outsourcing Model
  11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.4.9.1. Brazil
    11.4.9.2. Argentina
    11.4.9.3. Rest of South America
11.5. Asia-Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Stage
  11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Outsourcing Model
  11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  11.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.5.9.1. China
    11.5.9.2. India
    11.5.9.3. Japan
    11.5.9.4. South Korea
    11.5.9.5. Rest of Asia-Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Stage
  11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Outsourcing Model
  11.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

12.1. Competitive Overview and Key Market Players
12.2. Market Share Analysis and Positioning Matrix
12.3. Strategic Partnerships, Mergers & Acquisitions
12.4. Key Developments in Product Portfolios and Innovations
12.5. Company Benchmarking

13. COMPANY PROFILES

13.1. AbbVie Inc.*
  13.1.1. Company Overview
  13.1.2. Product Portfolio
    13.1.2.1. Product Description
    13.1.2.2. Product Key Performance Indicators (KPIs)
    13.1.2.3. Historic and Forecasted Product Sales
    13.1.2.4. Product Sales Volume
  13.1.3. Financial Overview
    13.1.3.1. Company Revenue
    13.1.3.2. Geographical Revenue Shares
    13.1.3.3. Revenue Forecasts
  13.1.4. Key Developments
    13.1.4.1. Mergers & Acquisitions
    13.1.4.2. Key Product Development Activities
    13.1.4.3. Regulatory Approvals, etc.
    13.1.4.4. SWOT Analysis
13.2. Boehringer Ingelheim International GmbH
13.3. Catalent, Inc
13.4. Charles River Laboratories
13.5. WuXi Biologics
13.6. CordenPharma
13.7. Rentschler Biopharma SE
13.8. Syngene International Limited (LIST NOT EXHAUSTIVE)

14. ASSUMPTIONS AND RESEARCH METHODOLOGY

14.1. Data Collection Methods
14.2. Data Triangulation
14.3. Forecasting Techniques
14.4. Data Verification and Validation

15. APPENDIX

15.1. About Us and Services
15.2. Contact Us